Erasca, Inc. (ERAS)
14.60
-1.18
(-7.48%)
USD |
NASDAQ |
Nov 13, 11:13
Erasca Net Income (Annual) : -124.55M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -124.55M |
| December 31, 2024 | -161.65M |
| December 31, 2023 | -125.04M |
| December 31, 2022 | -242.80M |
| Date | Value |
|---|---|
| December 31, 2021 | -122.76M |
| December 31, 2020 | -101.66M |
| December 31, 2019 | -12.04M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Twist Bioscience Corp. | -- |
| Immunome, Inc. | -212.39M |
| Oncolytics Biotech, Inc. | -28.76M |
| Sangamo Therapeutics, Inc. | -122.93M |